Drug treatment

Brostoff, Jonathan; Gamlin, Linda
January 1999
Asthma: The Complete Guide;1999, p318
Book Chapter
This section relates the experiences of asthmatics in managing asthma attacks. In the late 1960s, the real revolution in asthma drugs started, and that just transformed John's life. He still was not well after it, but he was so much better. Rachel has had asthma since childhood. She is much happier now that she manages without the inhalers, because she does not like taking drugs of any kind, and she prefers to feel that she can control the asthma herself.


Related Articles

  • Choosing Asthma Step-up Care. von Mutius, Erika; Drazen, Jeffrey M. // New England Journal of Medicine;3/18/2010, Vol. 362 Issue 11, p1042 

    The authors discuss how to choose the right step-up care for asthma, which is considered as an easy and hard medical condition to treat. They say that asthma is easy to treat because it requires little medication while it becomes hard when control is not obtained with the first choice of a...

  • Magnesium sulfate "remains uncommon" but appropriate for acute asthma.  // PharmacoEconomics & Outcomes News;1/28/2006, Issue 495, p3 

    Discusses research being done on the use of magnesium sulfate for acute asthma. Reference to study being done by B. H. Rowe et al, which appeared in the January 1, 2006 issue of the "Journal of Allergy and Clinical Immunology"; Therapeutic use of magnesium sulfate.

  • Warning on low quality asthma prescribing.  // Pulse;5/21/2005, Vol. 65 Issue 20, p17 

    Reports that general practitioners in Great Britain are relying too heavily on reliever medication for high-risk asthma patients and under-prescribing inhaled steroids. Research headed by Henry Chrystyn, professor of clinical pharmacology at the University of Bradford; Analysis of patients who...

  • Timing is everything. Ellis, Clare // Nature Reviews Drug Discovery;May2004, Vol. 3 Issue 5, p387 

    Looks at the study conducted by Richard Bond, et al, published in the 2004 issue of the "Proceedings of the National Academy of Sciences," indicating that beta-blockers which are presently contraindicated for asthmatics, might actually be able to prevent serious attacks. Influence of the...

  • Salmeterol/fluticasone of value for mild-to-moderate asthma.  // PharmacoEconomics & Outcomes News;7/14/2007, Issue 532, p1 

    The article presents a study on salmeterol/fluticasone for treatment of mild to moderate asthma. According to the research, the most cost effective first-line controller therapy in mild to moderate asthma is salmeterol/fluticasone propionate compared to fluticasone inhaled corticosteroids...

  • Script cost cuts asthma compliance. Goff, Ashleigh // Pulse;6/17/2009, Vol. 69 Issue 21, p10 

    The article presents a study on patients in Great Britain with asthma using preventive inhalers. Research has found that these patients do make poor potentially dangerous management decisions through skipping doses of inhaled steroids. Further, it has also appeared to strengthen the case for the...

  • Inhaler switch warning. Praities, Nigel // Pulse;5/7/2008, Vol. 68 Issue 16, p13 

    The article reports on the study from the University of Aberdeen which assesses the effectiveness of combined inhalers for asthma in Great Britain. The study reveals that the combined inhalers improve compliance and reduce the use of other healthcare products. Researchers argue that primary care...

  • Once daily oral controller therapy with low dose theophylline or montelukast was not effective in poorly controlled asthma.  // Evidence Based Medicine;Aug2007, Vol. 12 Issue 4, p115 

    The article comments on a study which examines whether adding once daily oral controller therapy to low dose theophylline or montelukast improves patient with poorly controlled asthma. The study found that once daily oral controller therapy with low dose theophylline or montelukast was not...

  • β -Agonists and Asthma: too much of a good thing? Shore, Stephanie A.; Drazen, Jeffrey M. // Journal of Clinical Investigation;Aug2003, Vol. 112 Issue 4, p495 

    Describes a possible mechanism for the worsening of asthma due to β-agonists and reveals a therapeutic target in the treatment of the disease. Description and function of β-agonists; Effect of too much β-agonists; Reason for the adverse effects of β-agonists.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics